Advances in Antioxidative Nanozymes for Treating Ischemic Stroke
January 2023
in “
Engineered Regeneration
”
Studysummary In this study, researchers highlighted the potential of antioxidative nanozymes as a promising treatment for ischemic stroke, due to their stability, cost-effectiveness, and ability to regulate ROS-induced inflammation, positioning them as a noteworthy alternative to natural enzymes like catalase and superoxide dismutase.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Antioxidative nanozymes offer a promising treatment for ischemic stroke by addressing the challenge of excess reactive oxygen species (ROS) generated during blood flow restoration in the brain. Unlike natural enzymes like catalase and superoxide dismutase, which are difficult to use widely, nanozymes provide high stability, low cost, and long-term storage benefits. These properties make them a viable therapeutic strategy, with potential significant contributions to both basic research and clinical applications in the field of ischemic stroke.
